Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis
F Jadidi-Niaragh, A Mirshafiey - Immunopharmacology and …, 2011 - Taylor & Francis
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous
system characterized by perivascular inflammation and demyelination and loss of …
system characterized by perivascular inflammation and demyelination and loss of …
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis
M Buc - Mediators of inflammation, 2013 - Wiley Online Library
Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the
axons of the brain and spinal cord are damaged, leading to demyelination and scarring as …
axons of the brain and spinal cord are damaged, leading to demyelination and scarring as …
Dysfunction of IL-10-producing type 1 regulatory T cells and CD4+ CD25+ regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys
A Ma, Z Xiong, Y Hu, S Qi, L Song, H Dun… - International …, 2009 - Elsevier
CD4+ CD25+ Treg and IL-10+ Tr1 cells play a major role in controlling autoimmunity by
suppressing self-reactive T cells. Dysfunction of Tregs appears to be a critical factor in the …
suppressing self-reactive T cells. Dysfunction of Tregs appears to be a critical factor in the …
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
R Liu, S Du, L Zhao, S Jain, K Sahay… - Frontiers in …, 2022 - frontiersin.org
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system
(CNS) characterized by destruction of the myelin sheath structure. The loss of myelin leads …
(CNS) characterized by destruction of the myelin sheath structure. The loss of myelin leads …
Regulatory T cells in multiple sclerosis
K Kimura - Clinical and Experimental Neuroimmunology, 2020 - Wiley Online Library
Regulatory T (Treg) cells are known to suppress excessive inflammation in autoimmune
diseases, including multiple sclerosis (MS). Accumulating evidence suggests that the …
diseases, including multiple sclerosis (MS). Accumulating evidence suggests that the …
Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications
V Mastorodemos, M Ioannou, P Verginis - Neuroimmunomodulation, 2015 - karger.com
Multiple sclerosis (MS) is a prototypic autoimmune inflammatory disorder of the central
nervous system (CNS). MS pathogenesis is a complex phenomenon that is influenced by …
nervous system (CNS). MS pathogenesis is a complex phenomenon that is influenced by …
Disturbed regulatory T cell homeostasis in multiple sclerosis
K Venken, N Hellings, R Liblau, P Stinissen - Trends in molecular medicine, 2010 - cell.com
The pathological features of multiple sclerosis (MS), a chronic inflammatory disorder of the
central nervous system, support an autoimmune etiology. Strong evidence has been …
central nervous system, support an autoimmune etiology. Strong evidence has been …
Regulatory T Cells in Multiple Sclerosis Diagnostics—What Do We Know So Far?
B Arneth - Journal of Personalized Medicine, 2023 - mdpi.com
Background: Multiple sclerosis (MS) is an autoimmune disorder that affects the central
nervous system (CNS) through inflammation. MS symptoms become acute if the disease …
nervous system (CNS) through inflammation. MS symptoms become acute if the disease …
Characterization of regulatory t-cells in multiple sclerosis patients treated with interferon beta-1a
Background: Regulatory T-Cells (Treg Cells), as one of the immune system components,
have been highly effective in the autoimmune diseases prevention, particularly multiple …
have been highly effective in the autoimmune diseases prevention, particularly multiple …
[HTML][HTML] Interferon-beta therapy of multiple sclerosis patients improves the responsiveness of T cells for immune suppression by regulatory T cells
B Trinschek, F Luessi, CC Gross, H Wiendl… - International Journal of …, 2015 - mdpi.com
Multiple sclerosis (MS) is an inflammatory autoimmune disease characterized by
imbalanced immune regulatory networks, and MS patient-derived T effector cells are …
imbalanced immune regulatory networks, and MS patient-derived T effector cells are …
相关搜索
- regulatory t cells sclerosis patients
- regulatory t cell orchestra leader
- regulatory t cells immune suppression
- immune suppression sclerosis patients
- regulatory t cells beta 1a
- regulatory t cells biological therapy
- regulatory t cells sclerosis diagnostics
- responsiveness of t cells immune suppression
- responsiveness of t cells sclerosis patients
- regulatory t cells interferon beta